EPHA2 and glioblastoma: Co-IP-MS analysis using LN18PDGFRA−/− showed EPHA2 could interact with PDGFA (Dataset 3), which was confirmed by Co-IP and western blotting in GBM cells (Fig. 2g) or through in vitro protein binding assay (Supplementary Fig. S2g).